Tissue microarray technology: principles, pitfalls and perspectives - lessons learned from hematological malignancies

Detection, validation and incorporation into clinical use of new diagnostic, prognostic and therapeutic molecular targets in modern medical science should be time- and cost-efficient. Here, we discuss the principles, advantages, disadvantages and possible pitfalls of tissue microarray (TMA) technology, a powerful tool for high throughput large-scale morphological in situ analysis of molecular targets. Based on recent observations from molecular profiling of hernatological malignancies, we review potential TMA applications assessing molecular targets in large collectives of tissue specimens. (c) 2005 Elsevier Inc. All rights reserved.